45
Ensysce Biosciences, Inc. raises $2.2M under Reg D
Company raise · Closed · Offering $2.2M · Sold $2.2M · LA JOLLA, CA · filed 2025-04-25
Placement agent engaged
60
Ensysce Biosciences, Inc. raises $77.2M under Reg D
Company raise · Closed · LA JOLLA, CA · Form D filed 2026-08-20
$50M+ raisePlacement agent engagedBusiness combination
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| William Lynn Chang | Director |
| Bob Lynn Gower | Director |
| Adam Lynn Levin | Director |
| D Lynn Kirkpatrick | Executive Officer, Director |
| Steve Lynn Martin | Director |
| David Lynn Humphrey | Executive Officer |
| James Lynn Morrison | Executive Officer, Director |
Signed by Dr. Lynn Kirkpatrick, CEO.
Placement agents / sales compensation: UBS Securities LLC; Cantor Fitzgerald & Co.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
45
Ensysce Biosciences, Inc. raises $1.1M under Reg D
Company raise · Closed · Offering $1.1M · Sold $1.1M · LA JOLLA, CA · filed 2025-04-14
Placement agent engaged